Therapeutics and inflammatory bowel disease: A guide to the interpretation of randomized controlled trials

被引：25
|
作者：
Feagan, BG
McDonald, JWD
Koval, JJ
机构：
[1] UNIV WESTERN ONTARIO, DEPT MED, LONDON, ON, CANADA
[2] UNIV WESTERN ONTARIO, DEPT EPIDEMIOL & BIOSTAT, LONDON, ON, CANADA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 01期
关键词：
D O I：
10.1053/gast.1996.v110.pm8536868
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Randomized controlled trials are the optimal means of assessing the efficacy of new treatments, This report reviews the methodology of clinical trials in inflammatory bowel disease using examples from recent randomized trials of therapy for Crohn's disease and other gastrointestinal diseases to show key principles, Guidelines for the practicing clinician to evaluate these studies are provided.
引用
收藏
页码：275 / 283
页数：9
相关论文
共 50 条
  • [1] Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease
    Ma, Christopher
    Jairath, Vipul
    Feagan, Brian G.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Sands, Bruce E.
    Panaccione, Remo
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (11) : 792 - 808
  • [2] Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease?
    Temido, Maria Jose
    Honap, Sailish
    Danese, Silvio
    Jairath, Vipul
    Magro, Fernando
    Portela, Francisco
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [3] Challenges to the Design, Execution, and Analysis of Randomized Controlled Trials for Inflammatory Bowel Disease
    D'Haens, Geert
    Feagan, Brian
    Colombel, Jean-Frederic
    Sandborn, William J.
    Reinisch, Walter
    Rutgeerts, Paul
    Carbonnel, Frank
    Mary, Jean-Yves
    Danese, Silvio
    Fedorak, Richard N.
    Hanauer, Steven
    Lemann, Marc
    GASTROENTEROLOGY, 2012, 143 (06) : 1461 - 1469
  • [4] Randomized Clinical Trials in Inflammatory Bowel Disease
    Cottone, Mario
    REVIEWS ON RECENT CLINICAL TRIALS, 2012, 7 (04) : 255 - 255
  • [5] Cluster Randomized Trials: Lessons for Inflammatory Bowel Disease Trials
    Caron, Benedicte
    D'Amico, Ferdinando
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (02): : 312 - 318
  • [6] Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials
    Wedlake, Linda
    Slack, Natalie
    Andreyev, H. Jervoise N.
    Whelan, Kevin
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (03) : 576 - 586
  • [7] Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
    Ghouri, Yezaz A.
    Richards, David M.
    Rahimi, Erik F.
    Krill, Joseph T.
    Jelinek, Katherine A.
    DuPont, Andrew W.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 473 - 487
  • [8] Barriers to enrollment in inflammatory bowel disease randomized controlled trials: An investigation of patient perspectives
    Ravikoff, Jessica E.
    Cole, Elisabeth B.
    Korzenik, Joshua R.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (11) : 2092 - 2098
  • [9] Probiotics in inflammatory bowel disease: Controlled trials and perspectives
    Seksik, P
    Marteau, P
    THERAPIE, 2004, 59 (01): : 83 - 87
  • [10] Vedolizumab for inflammatory bowel disease: from randomized controlled trials to real-life evidence
    Scribano, Maria Lia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (23) : 2457 - 2467
12345